Medline PE Shareholders Price Upsized $2.69B Secondary Offering at $37.00
MDLN is trading near its 52-week low of $35.5 (4.7% above the low) on elevated volume (2.3× avg).
Summary
Medline Inc. has priced an upsized secondary offering of 72.6 million shares at $37.00 each, totaling approximately $2.69 billion. This follows recent SEC filings by major private equity shareholders, including Blackstone, Carlyle, and Hellman & Friedman, who are selling their stakes. This is the second significant secondary offering by these PE firms this year, with a previous 75 million share sale in March. The substantial share sale, priced near the stock's 52-week low, could exert downward pressure on the stock as these large investors continue to exit their positions.
At the time of this announcement, MDLN was trading at $37.16 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $48.7B. The 52-week trading range was $35.50 to $50.88. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.